The FDA has approved Korlym (mifepristone)(formerly Corlux) from Corcept Therapeutics to control high blood sugar levels (hyperglycemia) in adults with...
Strongbridge Biopharma announced the top-line findings from the extended evaluation phase of the pivotal Phase III SONICS study of Recorlev...
Strongbridge Biopharma plc, announced top-line results from the multinational, pivotal Phase III SONICS study evaluating Recorlev (levoketoconazole) for the treatment...